Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

carboplatin

  • Open Access
    Comparing Injection Site Reactions of Aprepitant and Fosaprepitant in Gynecologic Cancer Chemotherapy
    SEIRA NISHIBE-TOYOSATO, YOSUKE ANDO, YUTAKA TORII, RYOKO ICHIKAWA, AKIKO OWAKI, HIRONORI MIYAMURA, EIJI NISHIO, HIDEZO MATSUDA, NAHO TSUJII-FUJII, AKANE SHIMATO-ISOBE, KOTONE MUKAIJI, KAORI ITO, TAKAHIRO HAYASHI, TAKUMA FUJII and SHIGEKI YAMADA
    In Vivo September 2024, 38 (5) 2374-2382; DOI: https://doi.org/10.21873/invivo.13704
  • Open Access
    Optimal Number of Cycles of First-line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
    AKINORI MINATO, DAICHI OHNO, KAZUKI MUROOKA, YUTAKA OKUMURA, TOMOHISA TAKABA, KATSUYOSHI HIGASHIJIMA, YUJIRO NAGATA, IKKO TOMISAKI, KENICHI HARADA and NAOHIRO FUJIMOTO
    In Vivo July 2024, 38 (4) 1927-1934; DOI: https://doi.org/10.21873/invivo.13648
  • Open Access
    Tracheobronchial Adenoid Cystic Carcinoma Treated Successfully With Chemoradiotherapy Followed by Durvalumab: A Case Report
    YU NAKATANI, TETSUYA KUBOTA, YOSHIAKI HIRAKAWA, TAKASHI ANAYAMA, TOMOKI KIMURA and AKIHITO YOKOYAMA
    In Vivo May 2024, 38 (3) 1483-1488; DOI: https://doi.org/10.21873/invivo.13595
  • Open Access
    A Phase I Trial of Weekly Nab-paclitaxel Plus Carboplatin With Thoracic Radiotherapy for Non-small Cell Lung Cancer
    TETSUYA KUBOTA, MIZU SAKAI, KAZUKI ANABUKI, KAZUFUMI TAKAMATSU, KENICHI MUKAIDA, KANA KOBAYASHI, TAKUJI YAMAGAMI and AKIHITO YOKOYAMA
    In Vivo January 2024, 38 (1) 259-263; DOI: https://doi.org/10.21873/invivo.13433
  • You have access
    Paclitaxel and Carboplatin Versus Cisplatin and 5-Fluorouracil in Concurrent Chemoradiotherapy in Patients With Esophageal Cancer
    PO-HSU SU, SHUN-WEN HSUEH, CHEN-KAN TSENG, MING-MO HO, PO-JUNG SU, CHIA-YEN HUNG, KUN-YUN YEH, PEI-HUNG CHANG, YU-SHIN HUNG, YA-WEN HO, YU-CHING LIN and WEN-CHI CHOU
    In Vivo November 2021, 35 (6) 3391-3399; DOI: https://doi.org/10.21873/invivo.12638
  • You have access
    Modification of Platinum-based Systemic Chemotherapy for Advanced Urothelial Carcinoma in Patients With Suboptimal Renal Function
    AKIHIRO HAMADA, TAKESHI SANO, KEIYU MATSUMOTO, TORU SAKATANI, KENJI NAKAMURA, ATSURO SAWADA, SHUSUKE AKAMATSU, YOSHIYUKI MATSUI, OSAMU OGAWA and TAKASHI KOBAYASHI
    In Vivo September 2021, 35 (5) 2821-2829; DOI: https://doi.org/10.21873/invivo.12569
  • You have access
    Evaluation of Blood-based Biomarkers for Prediction of Response in Carboplatin-treated Metastatic Castration-resistant Prostate Cancer Patients
    JENNIFER MORITZ, THOMAS BAUERNHOFER, SEBASTIAN MANNWEILER, TANJA LANGSENLEHNER, KARL PUMMER, NADIA DANDACHI and MARTIN PICHLER
    In Vivo November 2020, 34 (6) 3631-3638; DOI: https://doi.org/10.21873/invivo.12209
  • You have access
    Readministration of Platinum Agents in Recurrent Ovarian Cancer Patients Who Developed Hypersensitivity Reactions to Carboplatin
    CHIKAGE NARUI, HIROSHI TANABE, JASON S. SHAPIRO, YOKO NAGAYOSHI, TAKENORI MARUTA, MOMOKO INOUE, YUKIHIRO HIRATA, HIROMI KOMAZAKI, HIROKUNI TAKANO, SHIGEKI NIIMI, SEIJI ISONISHI and AIKOU OKAMOTO
    In Vivo November 2019, 33 (6) 2045-2050; DOI: https://doi.org/10.21873/invivo.11702
  • You have access
    Carboplatin and Docetaxel in Patients With Salivary Gland Carcinoma: A Retrospective Study
    TAKURO OKADA, TAKASHI SAOTOME, TOSHITAKA NAGAO, TATSUO MASUBUCHI, CHIHIRO FUSHIMI, TAKASHI MATSUKI, HIDEAKI TAKAHASHI, KOUKI MIURA, KIYOAKI TSUKAHARA and YUICHIRO TADA
    In Vivo May 2019, 33 (3) 843-853; DOI: https://doi.org/10.21873/invivo.11549
  • You have access
    Pentoxifylline Enhances the Apoptotic Effect of Carboplatin in Y79 Retinoblastoma Cells
    CLAUDIA CAROLINA CRUZ-GALVEZ, PABLO CESAR ORTIZ-LAZARENO, ELIZA JULIA PEDRAZA-BRINDIS, MARIA MARTHA VILLASENOR-GARCIA, EMMANUEL REYES-URIBE, ALEJANDRO BRAVO-HERNANDEZ, RAUL ANTONIO SOLIS-MARTINEZ, MARTHA CANCINO-MARENTES, CRISTINA RODRIGUEZ-PADILLA, ALEJANDRO BRAVO-CUELLAR and GEORGINA HERNANDEZ-FLORES
    In Vivo March 2019, 33 (2) 401-412; DOI: https://doi.org/10.21873/invivo.11487

Pages

  • Next
  • 1
  • 2
In Vivo

© 2026 In Vivo

Powered by HighWire